|
|
| | Adomeglivant Basic information |
| Product Name: | Adomeglivant | | Synonyms: | Adomeglivant;LY-2409021;β-Alanine, N-[4-[(1S)-1-[[4'-(1,1-dimethylethyl)-2,6-dimethyl[1,1'-biphenyl]-4-yl]oxy]-4,4,4-trifluorobutyl]benzoyl]-;Adomeglivant ( LY2409021) | | CAS: | 1488363-78-5 | | MF: | C32H36F3NO4 | | MW: | 555.64 | | EINECS: | | | Product Categories: | | | Mol File: | 1488363-78-5.mol |  |
| | Adomeglivant Chemical Properties |
| Boiling point | 656.7±55.0 °C(Predicted) | | density | 1.173±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO:100.0(Max Conc. mg/mL);179.97(Max Conc. mM)
Ethanol:100.0(Max Conc. mg/mL);179.97(Max Conc. mM) | | form | A solid | | pka | 4.28±0.10(Predicted) | | color | White to off-white |
| | Adomeglivant Usage And Synthesis |
| Uses | Adomeglivant is a glucagon receptor antagonist used in the combined treatment of type 2 diabetes. |
| | Adomeglivant Preparation Products And Raw materials |
|